CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

EU Indices slightly down this morning TA focus on Vivendi

Article By: ,  Financial Analyst

EU Indices slightly down this morning | TA focus on Vivendi

INDICES
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.

EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).

The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.

SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate

Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services

Europe worst 3 sectors
utilities, telecommunications, health care

INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).

ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%

MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).

Spot gold remained subdued at $1,680 an ounce.


#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."

Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.

Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley. 

Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.


#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."

Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.


Source: GAIN Capital, TradingView

Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.


#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."


#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.


EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024